Because retatrutide is not yet licensed in the UK, it is not routinely available for prescribing outside a clinical trial or a specific MHRA access scheme (such as the Early Access to Medicines Scheme [EAMS] or named-patient unlicensed supply)
Grant, and C
Whether youre just starting your journey or restarting after setbacks, our team is here to support you with personalized care every step of the way
Unfortunately, due to the limited number of studies available, we could not provide a detailed subgroup analysis based on the specific GLP-1RAs classifications, procedure type, baseline patient characteristics, and the timing of therapy initiation
Previous studies of individuals affected by type 1 diabetes [37, 38] and AAb+ individuals [36] have revealed increased serum IGFBP1 levels
Beyond physical health, managing obesity improves energy levels, mobility, and emotional well-being